BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kou P, Wei S, Xiong F. Recent Advances of mTOR Inhibitors Use in Autosomal Dominant Polycystic Kidney Disease: Is the Road Still Open? Curr Med Chem 2019;26:2962-73. [PMID: 29600752 DOI: 10.2174/0929867325666180330094434] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang JQJ, Saravanabavan S, Rangan GK. Effect of Reducing Ataxia-Telangiectasia Mutated (ATM) in Experimental Autosomal Dominant Polycystic Kidney Disease. Cells 2021;10:532. [PMID: 33802342 DOI: 10.3390/cells10030532] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Sriwi D, Alabdaljabar MS, Jacob M, Mujamammi AH, Gu X, Sabi EM, Li L, Hussein MH, Dasouki M, Abdel Rahman AM. Metabolomics Profiling of Cystic Renal Disease towards Biomarker Discovery. Biology (Basel) 2021;10:770. [PMID: 34440002 DOI: 10.3390/biology10080770] [Reference Citation Analysis]